Physician profile

Christopher B Morgan

Physical Medicine & Rehabilitation · Hinsdale, IL

NPI 1184702078

$291.31

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$15.29

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Collegium Pharmaceutical, INC. $101.44 2019-2020
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $68.31 2019
Biodelivery Sciences International, INC. $35.49 2019
Kaleo, INC. $22.79 2019
Depuy Synthes Sales INC. $22.40 2020
Exact Sciences Corporation $15.29 2023 Cologuard Collection Kit
Assertio Therapeutics, INC. $13.24 2019
Astrazeneca Pharmaceuticals LP $12.35 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christopher B Morgan

$291.31

in general payments reported 2019-2025

Years
2019-2023
Top company
Collegium Pharmaceutical, INC.

https://glasscript.com/doctor/144102/christopher-b-morgan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.